Will pharma finally score a policy win for 340B?
PharmaVoice
JUNE 16, 2025
The industry is awaiting guidance on a rebate approach to the contentious drug discount program for hospitals and aiming for tighter oversight. The 340B Drug Pricing Program has long been a contentious issue for pharma. The 340B Drug Pricing Program has long been a contentious issue for pharma.
Let's personalize your content